박한승 조교수
#골수이식#림프구성백혈병#림프종#다발골수종
|
학력
2011 .02 ~ 2016 .02울산대학교 의학 석사
2001 .03 ~ 2007 .02충남대학교 의학 학사
2001 .03 ~ 2007 .02충남대학교 의학 학사
경력
2017 .03 ~ 현재서울아산병원 혈액내과 임상조교수
2015 .05 ~ 2017 .02서울아산병원 혈액내과 임상강사(전임의, 펠로우)
2012 .03 ~ 2015 .04군복무(육군 군의관)
2008 .03 ~ 2012 .02서울아산병원 내과 전공의(레지던트)
2007 .03 ~ 2008 .02서울아산병원 수련의(인턴)
2015 .05 ~ 2017 .02서울아산병원 혈액내과 임상강사(전임의, 펠로우)
2012 .03 ~ 2015 .04군복무(육군 군의관)
2008 .03 ~ 2012 .02서울아산병원 내과 전공의(레지던트)
2007 .03 ~ 2008 .02서울아산병원 수련의(인턴)
논문
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic
Cell Transplantation in Patients with Refractory Acute Leukemia
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression.
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen?Haploidentical Hematopoietic
Cell Transplantation in Patients with Refractory Acute Leukemia
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5%―a feasibility study
Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Anti-leukemic effects of vosaroxin, an anti-cancer quinolone derivative, on hypomethylating agent resistant cells
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
A case of Tapia’s syndrome after self-extubation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
Inhibition of DNA methyltransferases by volasertib in HMA resistant cell lines
Treatment outcomes of myelodysplastic syndrome patients relapsing after allogeneic hematopoietic cell transplantation
A case of Tapia’s syndrome after self-extubation
Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia
Non-Myeloablative Conditioning for Lower-Risk Myelodysplastic Syndrome with Bone Marrow Blasts less than 5% ? a Feasibility Study
Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.